Labiana Health, S.A. (BME:LAB)

Spain flag Spain · Delayed Price · Currency is EUR
4.540
0.00 (0.00%)
At close: Feb 27, 2026
51.33%
Market Cap 31.76M
Revenue (ttm) 71.67M
Net Income (ttm) 904.36K
Shares Out 7.00M
EPS (ttm) 0.13
PE Ratio 35.12
Forward PE 12.59
Dividend n/a
Ex-Dividend Date n/a
Volume 493
Average Volume 886
Open 4.500
Previous Close 4.540
Day's Range 4.500 - 4.600
52-Week Range 2.793 - 4.900
Beta 0.15
RSI 52.07
Earnings Date Apr 22, 2026

About Labiana Health

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contrac... [Read more]

Sector Healthcare
Founded 1958
Employees 394
Stock Exchange Madrid Stock Exchange
Ticker Symbol LAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.